Chondroitin sulfate-degrading enzymes in human polymorphonuclear leukocytes: characteristics and evidence for concerted mechanism.
D000116:Acetylgalactosamine; D002803:Chondro-4-Sulfatase / Q000037:antagonists & inhibitors / Q000097:blood*; D002807:Chondroitin / Q000031:analogs & derivatives*; D002809:Chondroitin Sulfates / Q000097:blood*; D005966:Glucuronidase / Q000037:antagonists & inhibitors / Q000097:blood*; D006596:Hexosaminidases / Q000037:antagonists & inhibitors / Q000097:blood*; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D009504:Neutrophils / Q000201:enzymology*; D013429:Sulfatases / Q000097:blood*
D002807:Chondroitin; D002809:Chondroitin Sulfates; D013429:Sulfatases; D002803:Chondro-4-Sulfatase; D006596:Hexosaminidases; D005966:Glucuronidase; D000116:Acetylgalactosamine